Macular degeneration trials in Belgium

3 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Active, not recruiting
  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  Where

  Genk, Gent, Leuven

  Age

  60 years and over

  People

  274 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06635148 · EU 2022-500747-21-00
• Phase 3Taking people
  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Where

  Gent, Leuven

  Age

  50 years and over

  People

  561 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07007065 · EU 2024-512298-28-00
• Phase 3Completed
  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  Where

  Leuven

  Age

  50 years and over

  People

  1,000 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT03683251 · EU 2023-507131-38-00